#151083

Anti-HPV16E6 & HPV18E6 [C1P5]

Cat. #151083

Anti-HPV16E6 & HPV18E6 [C1P5]

Cat. #: 151083

Sub-type: Primary antibody

Unit size: 100 ug

Availability: 3-4 weeks

Target: Human Papilloma Virus-16 and 18 early protein 6 (HPV16E6 & HPV18 E6)

Class: Monoclonal

Application: IHC ; IP ; WB

Reactivity: Human papilloma virus

Host: Mouse

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Lawrence Banks

Institute: Cancer Research UK, London Research Institute: Lincoln's Inn Fields

Tool Details
Target Details
Applications
Handling
Related Tools
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: Anti-HPV16E6 & HPV18E6 [C1P5]
  • Cancer: Gynaecologic cancer
  • Cancers detailed: Cervical
  • Research fields: Cancer;Microbiology
  • Clone: C1P5
  • Tool sub type: Primary antibody
  • Class: Monoclonal
  • Conjugation: Unconjugated
  • Molecular weight: 15.8 kDa, 17 kDa
  • Strain: Balb/c
  • Reactivity: Human papilloma virus
  • Host: Mouse
  • Application: IHC ; IP ; WB
  • Description: C1P5 can be used for detection of HPV in cervical smears and biopsies and analysis of E6 expression in cell transformation studies.
  • Immunogen: Gel-purified HPV-18 E6-beta galactosidase fusion protein
  • Isotype: IgG1
  • Myeloma used: P3/NS1/1-Ag4.1

Target Details

  • Target: Human Papilloma Virus-16 and 18 early protein 6 (HPV16E6 & HPV18 E6)
  • Molecular weight: 15.8 kDa, 17 kDa
  • Target background: The human papilloma virus (HPV) family of DNA tumor viruses includes HPV-16 and HPV-18, which are associated with a large proportion of cervical cancer cases. HPV early proteins E6 and E7 are the major viral oncoproteins that regulate cell proliferation through the inactivation of p53 and Rb1 tumour suppressor proteins respectively.

Applications

  • Application: IHC ; IP ; WB

Handling

  • Format: Liquid
  • Concentration: 0.81 mg/ml
  • Unit size: 100 ug
  • Storage buffer: PBS with 0.02% azide
  • Storage conditions: '-15° C to -25° C
  • Shipping conditions: Shipping at 4° C

Related Tools

  • Related tools: Anti-HPV16E6 & HPV18E6, Recombinant [C1P5]

References

  • Xie et al. 2014. Oncogene. 33(8):1037-46. PMID: 23474763.
  • Herfs et al. 2012. Proc Natl Acad Sci U S A. 109(26):10516-21. PMID: 22689991.
  • Lawson et al. 2009. Br J Cancer. 101(8):1351-6. PMID: 19773762.
  • Zhang et al. 2005. J Biol Chem. 280(39):33165-77. PMID: 15983032.
  • Banks et al. 1987. J Gen Virol. 68 ( Pt 5):1351-9. PMID: 3033140.